Key technologies and capabilities for this role
Common questions about this position
Candidates need a minimum of three years of outside field sales experience in the healthcare sector, directly calling upon providers in the specified geographic territory, along with a demonstrated successful sales track record, effective selling skills, and excellent organizational and communication skills.
This is a field sales position requiring work throughout a specific territory in Detroit, including prospecting, attending tradeshows, and managing relationships with OBGYNs, MFMs, and other providers.
BillionToOne fosters a culture of transparency that fuels trust, collaboration that drives breakthroughs, and values every voice in the mission to transform healthcare with 10x better diagnostics, uniting talented professionals passionate about innovation and precision medicine.
The role focuses on increasing utilization of the UNITY Fetal Risk Screen through direct sales to OBGYNs, MFMs, and Genetic Counselors, prospecting new business, managing key relationships, and creating strategic business plans for growth in the Detroit territory.
A strong candidate has at least three years of successful field sales experience in healthcare, particularly with diagnostic or genetic testing, a proven sales track record (national awards are a plus), and strong presentation, listening, and relationship-building skills.
Molecular diagnostics for prenatal and oncology testing
BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair resolution, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne emphasizes accuracy, efficiency, and accessibility in molecular testing, providing diagnostic services directly to healthcare providers. Their goal is to positively impact healthcare by making molecular testing more reliable and available to everyone.